###### Key questions

What is already known about this subject?
=========================================

-   Trained cardiac genetic healthcare professionals in cardiology outpatient services have been shown to increase familial detection rate of cardiac-inherited diseases, such as hypertrophic cardiomyopathy and long QT syndrome, in a cost-effective manner and increase patient satisfaction. No such information exists for inpatient cardiac services.

What does this study add?
=========================

-   Family histories taken by cardiology inpatient teams from patients potentially affected by cardiac-inherited diseases, are usually insufficient to diagnose these conditions or to identify at-risk family members. However, when trained cardiac genetic healthcare professionals elicit at least a three-generation family pedigree, detection of cardiac-inherited diseases increases. This facilitates appropriate use of cardiac and genetic testing and allows risk reduction not only in the proband, but also their presymptomatic relatives.

How might this impact on clinical practice?
===========================================

-   Cardiology inpatient staff should be advised to obtain multigenerational pedigrees during the evaluation of cardiology inpatients, particularly in cases of non-ischaemic cardiomyopathy and resuscitated cardiac death. Training and time is required for this which can be facilitated and led by an allied professional within cardiology services and with links to a cardiac genetic service.

Introduction {#s1}
============

Cardiac-inherited diseases such as hypertrophic cardiomyopathy or long QT syndrome (LQTS) are individually relatively rare but collectively common.[@R1] Presenting symptoms include dyspnoea, syncope, arrhythmias and even sudden unexpected cardiac arrest.

Timely identification of cardiac-inherited diseases is paramount because there is extensive evidence that the risk of sudden death can be significantly reduced with a variety of management options, including β-blockers,[@R2] [@R3] implantable cardiac defibrillators (ICDs)[@R4] [@R5] and lifestyle modification.[@R6] Studies of such autosomal-dominant conditions have shown that it is possible to identify up to 8--9 affected family members per proband.[@R7] [@R8] Non-ischaemic dilated cardiomyopathy (DCM) may be familial in up to 40%,[@R9] and thorough investigation of non-coronary disease-related resuscitated sudden cardiac death (RSCD), including pharmacological provocative testing reveals an inherited cause in up to 60%.[@R12]

Therefore, consideration of familial cardiac-inherited diseases, even in seemingly isolated cases of structural or electrical disorders, and prompt diagnosis of a potential new proband is of vital importance regardless of their presentation, as many other unidentified family members may also be at risk.[@R8] [@R13] [@R14]

As a result of these combined observations, a proactive, integrated approach from cardiology and genetics professionals is recommended.[@R15] [@R16] Central to this is an in-depth, multigenerational family history (FHx). This has the potential to establish a diagnosis, avoid unnecessary, extensive and potentially expensive testing for underlying conditions, and can assist with devising a genetic testing strategy, interpreting genetic test results, and providing ongoing risk assessments for sudden cardiac death (SCD).[@R14] [@R17] However, to our knowledge, there are no other studies of the everyday practice of inpatient cardiology units to see if these guidelines are being adhered to, nor any to demonstrate the overall effect of their enforced introduction in these institutions.

New Zealand has a National Cardiac Inherited Disease Registry run by a multidisciplinary clinical and scientific network called the Cardiac Inherited Disease Group (CIDG).[@R13] Two new part-time coordinators (both experienced cardiac nurses) in two large district hospitals each with a regional cardiology referral base noted FHx of people at high risk of having a cardiac-inherited disease was not always performed by the cardiology inpatient team, and that patients could be discharged without identification of the underlying aetiology of their symptoms. Since cardiac-inherited diseases remain a differential diagnosis in presentations such as syncope, heart failure or RSCD, the coordinators were aware that FHx could potentially improve accuracy of diagnosis and improve quality of care for the patient and their family. Therefore, we wanted to test the following hypotheses: That documentation of family histories in inpatient hospital records was inadequate, andThat a multigenerational family tree obtained by a trained allied professional could lead to the increased detection of hitherto unrecognised familial cardiac disease.

Methods {#s2}
=======

Two experienced cardiac nurses were educated in cardiac-inherited diseases and employed as part time regional coordinators[@R13] within their tertiary adult cardiology services.

Patients were admitted, as usual, to the tertiary adult cardiac referral centre directly, or via transfer, from their local hospital. Over a 6-month period, through liaising with the relevant cardiology staff, they identified hospital inpatients who were definitely or potentially affected by cardiac-inherited disease. This included those who were already diagnosed, newly diagnosed through inpatient cardiac investigation, or had a FHx of cardiac-inherited disease, or those who presented with heart failure, sudden death including motor vehicle accidents, events during swimming and 'heart attacks' with unknown aetiology. Presence of permanent pacemakers and ICDs was elicited and other symptoms consistent with undiagnosed cardiac conditions were documented. The aim was to offer family cascade screening.

Coordinators took a 'full' FHx, including drawing at least a three-generation family tree, with syncope, young sudden death and cardiac disease documented. Additional baseline demographic data were also obtained. Admission presentations were recorded as documented in the clinical notes by the admitting physician and those with clinically apparent vasovagal syncope were not included.

The original clinical notes taken by the admitting staff were retrospectively reviewed and qualitatively compared for quality and content of FHx documentation.

Ethical approval {#s2a}
----------------

All patients were enrolled prospectively with the Cardiac Inherited Diseases Registry New Zealand. At this time, they provided informed consent for their de-identified clinical data to be used in research publications. The Cardiac Inherited Diseases Registry New Zealand, and the consent forms used were given multiregional (national) ethical approval by the New Zealand Health and Disability Ethics Committees AKX/02/00/107/AM02.[@R13] Consent forms can be reviewed at <http://www.cidg.org.nz>. Patients with a proven cardiac-inherited disease were subsequently offered genetic counselling, genetic testing and clinical family screening as recommended by international guidelines.[@R15] [@R16] [@R18]

Results {#s3}
=======

Thirty-seven patients were recruited: 22 males and 15 females with a mean age of 51 (range 15--79; [table 1](#OPENHRT2015000329TB1){ref-type="table"}). Clinical presentation included RSCD,[@R14] dyspnoea or heart failure,[@R11] and ventricular tachycardia[@R2] ([figure 1](#OPENHRT2015000329F1){ref-type="fig"}A). Their diagnoses, after inpatient cardiology investigation, are documented in [figure 1](#OPENHRT2015000329F1){ref-type="fig"}B.

###### 

Details of cohort showing the initial presentations of 37 cardiology inpatients with presentations of unknown aetiology, their discharge diagnoses after inpatient assessment according to the CIDG registry coordinators, and whether a family history was used by the cardiology inpatient team or the CIDG registry coordinators to determine whether patients were potentially affected by a CID

  Patient   Age   Clinical presentation   Final diagnosis                   Familial condition identified by cardiology team   Familial condition identified by coordinators
  --------- ----- ----------------------- --------------------------------- -------------------------------------------------- -----------------------------------------------
  1         15    RSCD                    LQTS                              N                                                  N
  2         39    Syncope                 Atrioventricular block            N                                                  N
  3         58    RSCD                    DCM                               N                                                  N
  4         48    Dyspnoea                DCM                               N                                                  N
  5         26    Chest pain              Infiltrative cardiomyopathy       N                                                  N
  6         47    RSCD                    Unknown                           N                                                  N
  7         21    RSCD                    Unknown                           N                                                  N
  8         51    RSCD                    Unknown                           N                                                  N
  9         57    Chest pain              NSTEMI, known HCM                 N                                                  Y
  10        64    RSCD                    Other---viral myocarditis         N                                                  N
  11        58    Syncope                 DCM                               N                                                  Y
  12        72    RSCD                    DCM                               N                                                  Y
  13        66    Chest pain              NSTEMI, obligate LQTS carrier\*   N                                                  Y
  14        44    RSCD                    Unknown                           N                                                  N
  15        57    Chest pain              ARVC                              N                                                  N
  16        49    Presyncope              BrS                               N                                                  N
  17        62    Dyspnoea                DCM                               N                                                  Y
  18        58    Dyspnoea                DCM                               N                                                  N
  19        62    Dyspnoea, known DCM     DCM                               N                                                  N
  20        60    Dyspnoea, known DCM     DCM                               N                                                  Y
  21        49    VT                      DCM                               N                                                  N
  22        20    Abdominal pain          DCM                               N                                                  Y
  23        62    Dyspnoea                DCM                               N                                                  Y
  24        20    RSCD                    DCM                               N                                                  N
  25        68    Heart failure           DCM                               N                                                  N
  26        70    Presyncope              DCM                               N                                                  N
  27        43    Dyspnoea                DCM                               N                                                  Y
  28        54    Dyspnoea                DCM                               N                                                  N
  29        50    VT                      DCM                               N                                                  N
  30        25    RSCD                    Other---electrocution             N                                                  N
  31        19    RSCD                    HCM                               N                                                  N
  32        79    Heart failure           HCM                               N                                                  N
  33        48    RSCD                    LVNC                              N                                                  Y
  34        55    RSCD                    Unknown                           N                                                  N
  35        34    RSCD                    Unknown                           N                                                  N
  36        45    Chest pain              HCM                               N                                                  Y
  37        57    Dyspnoea                HCM                               N                                                  Y

\*This patient was diagnosed with a NSTEMI, the cardiology inpatient assessment included FHx documenting 'LQTS'; however, FHx obtained by coordinator revealed he was an obligate LQTS carrier.

ARVC, arrhythmogenic right ventricular cardiomyopathy; BrS, Brugada syndrome; CID, cardiac-inherited disease; CIDG, Cardiac Inherited Disease Group; DCM, dilated cardiomyopathy; FHx, family history; HCM, hypertrophic cardiomyopathy; LQTS, long QT syndrome; LVNC, left ventricular non-compaction; NSTEMI, non-ST elevation myocardial infarction; RSCD, resuscitated sudden cardiac death; VT, ventricular tachycardia.

![Diagnosis at presentation and diagnoses finally reached at the end of the inpatient admission. (A) Mode of clinical presentation of 37 cardiology inpatients identified by the CIDG coordinators as definitely or possibly having inherited heart conditions. (B) Diagnoses of 37 patients after full assessment by both the inpatient cardiology team and CIDG registry coordinators. CIDG, Cardiac Inherited Disease Group; RSCD, resuscitated sudden cardiac death; VT, ventricular tachycardia; abdo pain, abdominal pain; DCM, dilated cardiomyopathy; HCM, hypertrophic cardiomyopathy; LQTS, long QT syndrome; ARVC, arrhythmogenic right ventricular cardiomyopathy; Brugada, Brugada syndrome; LVNC, left ventricular non-compaction.](openhrt2015000329f01){#OPENHRT2015000329F1}

Documentation of FHx by inpatient team {#s3a}
--------------------------------------

Twenty participants (54%) had no documentation of FHx during their admission (see [figure 2](#OPENHRT2015000329F2){ref-type="fig"}). Of the 17 patients (46%) who did have some FHx documented, 14 were insufficient to either identify or exclude a familial basis for their presentation. In three cases, where a familial condition was documented, the patients knew their diagnosis, its heritable nature and volunteered this to the treating physician (however, no FHx was documented by the cardiology team even after this occurred). Six patients had significant factual errors: one was an obligate LQTS carrier, two had unrecognized immediate family members with ICDs, and in the remaining three, clear diagnoses in first degree relatives was incorrectly reported (such as documenting a SCD which did not occur).

![Flow diagram of assessment of 37 cardiology inpatients. This compares the diagnostic success rate for detecting familial conditions between the regular inpatient cardiology team and the specialist CID nurses. CIDG, Cardiac Inherited Disease Group; CID, cardiac-inherited disease.](openhrt2015000329f02){#OPENHRT2015000329F2}

In comparison, when pedigrees were obtained by the coordinators, 29 (78%) patients were able to provide three full generations of FHx with sufficiently detailed clinical knowledge to enable appropriate assessment of heritability patterns (see [figure 2](#OPENHRT2015000329F2){ref-type="fig"}). All remaining patients were able to recall details for at least some of their family members. Twelve of the 29 pedigrees (41%) were strongly consistent with a heritable pathology for the patient\'s condition. Of these 12 patients, 5 had no FHx documented by the inpatient team, and 4 had inaccurate FHx documented. The remaining three had already been identified by the admitting team. Therefore, the link with an inherited disease had not been made in 9 of the 12 familial cases (see [table 1](#OPENHRT2015000329TB1){ref-type="table"} and [figure 2](#OPENHRT2015000329F2){ref-type="fig"} for details of entire cohort).

Full pedigrees took between 30 and 90 min to complete. Identification of unrelated familial conditions arose and through follow-up, a familial breast and ovarian cancer (BRCA1) mutation was exposed in one such case. Various factors impeded taking a thorough FHx, including the patient\'s physical condition (such as severe heart failure symptoms), emotional state and social or cultural values about health privacy. Family dynamics and structure such as adoption (n=2) also played an important part, particularly in some Ma¯ori patients where multiple adoptions in and out of the family is common cultural practice.[@R22] Low health literacy of the patient was also a common limiting factor as some patients did not comprehend the unfamiliar conditions of family members. In most cases, assistance from relatives was necessary in eliciting details of the family\'s demographics and health history which occasionally required a second consultation from the coordinator.

Discussion {#s4}
==========

This simple study demonstrates that detailed family histories are usually not obtained by inpatient general medical and cardiology staff, and when they are attempted, often contain significant errors and misleading information. In comparison, detailed family pedigrees can be effectively obtained by trained allied professionals, which can lead to the identification of inherited cardiac conditions.

To our knowledge, there are no other studies examining the impact of a cardiogenetics team in an inpatient cardiology service. By comparing inpatient hospital records with details obtained by the coordinators, we have seen an increased detection rate of cardiac-inherited diseases when such diseases are properly considered. While most patients seen in cardiology wards are discharged with a definitive diagnosis and underlying aetiology, such as coronary artery disease, this sample demonstrates that in the remainder of cases, the simple act of obtaining a FHx can reveal an inherited disease: 'idiopathic' becomes 'familial' in a striking number of cases. In many cases, the history was not subtle---containing multiple members with a cardiac transplant or death from DCM, for example. This study reveals the significant proportion of probands who would remain unrecognised without a supplemental assessment. With respect to the detection of presymptomatic individuals in the community,[@R13] for autosomal dominant conditions, it is possible to detect up to 8--9 affected relatives with extensive family cascade screening,[@R7] although 2--4 is more common.[@R13] Therefore, this simple diagnostic test, the FHx, also has important positive implications for the rest of the family and the community at large.[@R13] Cardiac genetic screening generally identifies 25--40% of asymptomatic relatives to be at some increased risk.[@R18] [@R23]

We document that a detailed three-generation pedigree provides valuable clinical information and increases detection rate of cardiac-inherited disease. However, we also found that it takes considerable time, and that input from family members is highly beneficial. In busy general cardiology practice, these factors are likely to significantly impede uptake of the latest consensus guidelines recommending cardiogenetics team involvement in the assessment and management of relevant patients.[@R15] Previous studies demonstrate the importance of specialised cardiac-inherited disease team presence in the outpatient setting, particularly in the investigation of sudden unexplained death and cardiac arrest.[@R7] [@R12] [@R24] [@R25] Our study identifies for the first time, the importance of a cardiac-inherited disease team presence in the inpatient setting. The diagnostic value of provocative pharmacological tests to detect mostly inherited arrhythmic substrates in cardiac arrest survivors has been established beyond doubt.[@R26] The present study reminds us that an essential part of that investigative algorithm is a thorough FHx,[@R24] and individual centres may wish to devise their own solution using skilled/trained cardiac nurses such as this study, genetic counsellors or to facilitate more time and training for their admitting physicians to perform this activity.

With the subsequent passage of time, our coordinators have noticed anecdotally an increased awareness of cardiac-inherited diseases among cardiology staff, and an increased rate of referrals. This has been facilitated by a specialised cardiac-inherited disease team inpatient presence, scheduled lectures for nursing, physiology staff and clinicians, as well as bedside clinical learning. Another positive effect is the increased awareness in general of the importance of the FHx with each patient.

A potential limitation of this paper is its performance in tertiary referral centres, and as such may not represent the general population. Furthermore, the referral to the CIDG coordinators was not systematic and it is possible that some other patients with similar conditions will have escaped the attention of the CIDG coordinator. While we consider it is likely that the cohort is representative of this section of cardiology inpatients, it may not be. Replication of this study in a larger cohort, with further assessment to determine effects on community and familial detection rate, cost-effectiveness (including diagnostic tests avoided) and patient satisfaction would be contributory.

When patient and families are seen in a specialised cardiac-inherited disease clinic, patient satisfaction has been consistently high.[@R27] It is imperative now to bring an element of that specialised knowledge into the inpatient cardiology wards. This study has shown that the addition of a standard, three-generation (minimum) family tree to an inpatient assessment is of itself a powerful diagnostic investigation which results in an increased rate of identification of cardiac-inherited diseases in probands and their relatives.

Conclusion {#s5}
==========

Family histories taken during inpatient cardiology admissions are usually either absent or inaccurate. Admitting cardiology staff needs to be reminded of the diagnostic value of a thorough FHx for the patient, family and potentially the community. The appointment of dedicated trained staff to obtain a full FHx results in a remarkably increased detection of cardiac-inherited diseases. Therefore, we suggest that protocols are developed and appropriate staff be trained and employed in all cardiology inpatient services.
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